Perioperative Management of Elevated HbA1c

HbA1c Thresholds for Surgical Decision-Making

The American Society of Anesthesiologists recommends delaying elective surgery and referring to endocrinology/diabetology if HbA1c is ≥8%, as this threshold represents significant glycemic imbalance that substantially increases perioperative morbidity and mortality 1, 2, 3
For elective surgery, HbA1c ≥8% mandates preoperative diabetology referral and delay of elective surgery until glycemic control improves 1, 2, 3
The American Diabetes Association suggests that HbA1c 6.5-8% allows for proceeding with surgery but implements intensive perioperative glucose monitoring 3
HbA1c <5% indicates excessive hypoglycemia risk and requires diabetology consultation before proceeding 1, 2
For cardiac surgery specifically, the American Heart Association recommends targeting HbA1c <6.5% preoperatively, with optimal control defined as <7% 3

The American College of Surgeons states that perioperative hyperglycemia >180 mg/dL increases morbidity, particularly infectious complications, and mortality 4, 5
Glucose >250 mg/dL carries a 10-fold higher risk of complications 4
Elevated HbA1c correlates with delayed wound healing and increased infection rates across all surgical specialties 4

The Society of Critical Care Medicine recommends maintaining intraoperative glucose 90-180 mg/dL to balance infection risk against hypoglycemia 4, 5
Avoid strict normoglycemia targets as this increases hypoglycemia frequency without improving outcomes 4, 5
The American Society of Anesthesiologists suggests using continuous IV insulin infusion via electronic syringe for type 1 diabetes, insulin-requiring type 2 diabetes, or stress hyperglycemia 4, 5

The American Society of Regional Anesthesia and Pain Medicine prioritizes regional anesthesia when feasible, as it provides superior postoperative pain control and reduces insulin resistance 4, 5
Prevent hypothermia aggressively 4
Implement multimodal analgesia to facilitate early bowel function recovery 4
Minimize blood loss 4
Encourage early ambulation 4
Utilize minimally invasive surgical techniques when possible 4

The American Diabetes Association recommends discontinuing SGLT2 inhibitors 3-4 days before surgery to prevent euglycemic diabetic ketoacidosis 3, 6
Hold metformin on the day of surgery 6
Continue hourly capillary blood glucose monitoring until patient is fully conscious and capable of self-management 5
Maintain glucose infusion (10% dextrose at 40 mL/hour) for insulin-dependent patients to prevent recurrent hypoglycemia 5

The American Society of Anesthesiologists advises against relying on continuous glucose monitors (CGM) intraoperatively due to lag time and perfusion-dependent inaccuracy 5
Never stop insulin pumps without immediate IV insulin replacement in type 1 diabetes patients, as ketoacidosis develops within hours 5
Recognize that 40% of type 1 diabetics and 10% of insulin-treated type 2 diabetics have hypoglycemia unawareness, requiring more vigilant monitoring 5
Refer to endocrinology/diabetology in scenarios such as HbA1c <5% or >8% in known diabetics, newly discovered diabetes during preoperative evaluation, HbA1c >9% during hospitalization, blood glucose >300 mg/dL, and difficulty resuming previous diabetes treatment postoperatively 1, 2, 6